Gufic Group

Mumbai, India Founded: 1970 • Age: 56 yrs
Lyophilized injections and pharmaceutical products are manufactured across therapeutic segments.
Annual revenue $96.0M Latest available
Total funding - Funding intelligence
Employees 1990 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors - Brand Intelligence

About Gufic Group

Gufic Group is a company based in Mumbai (India) founded in 1970. The company has 1,990 employees as of March 31, 2024.

  • Headquarter Mumbai, India
  • Employees 1990 as on 31 Mar, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Gufic Biosciences Limited
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $95.98 M (USD)
    1.63
    as on Mar 31, 2025
  • Net Profit
    $8.15 M (USD)
    -19.14
    as on Mar 31, 2025
  • EBITDA
    $16.39 M (USD)
    -6.47
    as on Mar 31, 2025
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    1990

    as on Mar 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Gufic Group

Gufic Group is a publicly listed company on the NSE with ticker symbol GUFICBIO in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NSE · Ticker: GUFICBIO · Sector: Health technology · India

Funding Insights of Gufic Group

Premium access

Detailed funding history for Gufic Group

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Gufic Group

Investments
Premium access

Investment portfolio details for Gufic Group

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Gufic Group

Premium access

Detailed financials for Gufic Group

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Gufic Group Comparisons

Gufic Group Primary company
Description
Lyophilized injections and pharmaceutical products are manuf...
Location
Mumbai, India
Founded Year
1970
Annual Revenue
$95.98 M (USD)
Net Profit
$8.15 M (USD)
EBITDA
$16.39 M (USD)
Employees
1,990
As of 2024
Premium access

Peer comparison for Gufic Group

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Gufic Group

Premium access

Detailed competitors of Gufic Group

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Gufic Group

Premium access

Complete news archive for Gufic Group

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gufic Group

Gufic Group was founded in 1970.

Gufic Group is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Jayesh Choksi is the current CEO of Gufic Group.

As of Mar 31, 2024, the latest employee count at Gufic Group is 1,990.

Annual revenue of Gufic Group is $95.98M as on Mar 31, 2025.

Founded in 1970 in Mumbai, India, pharmaceutical and herbal products including lyophilized injections are produced by the company. Operations center on a fully automated lyophilization plant that supports manufacturing in multiple therapeutic areas. Supplies are directed to major hospital chains and medical facilities. Research and development is conducted to develop new formulations and refine existing ones. Contract manufacturing of bulk drugs and active pharmaceutical ingredients is also handled.

Yes, Gufic Group is publicly traded on NSE under the ticker symbol GUFICBIO.

The ticker symbol of Gufic Group is GUFICBIO on NSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available